Dr. Daniela Peixoto was hired to work on the project entitled Drug Discovery for p53 PPI-targets. This project is financed by the Portuguese Science Foundation (FCT) to discover and develop novel molecules able of inhibiting the p53–MDM2/X interaction. The computational… Read more ›
Inactivation of the p53 tumor suppressor protein by interaction with murine double minute (MDM) proteins, MDM2 and MDMX, is a common event in human tumors expressing wild-type p53. In these tumors, the simultaneous inhibition of these interactions with MDMs, for… Read more ›
One of the most appealing targets for anticancer treatment is the p53 tumor suppressor protein. In half of human cancers, this protein is inactivated due to endogenous negative regulators such as MDM2. Actually, restoring the p53 activity, particularly through the… Read more ›